Solstice Biologics is a private company focused on solving the problem of targeting and delivery of nucleic acid therapeutics. The company is developing small, cell-permeable RNAi pro-drugs that can enter many different cell types and deliver on the promise of RNAi therapeutics.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 01/04/12 | $18,000,000 | Series A |
Aeris Capital VenBio | undisclosed |
